XRCC4 and lung cancer: The results indicating that cAMP signaling modulates both phosphorylation of DNA-PKcs and recruitments of XRCC4/DNA ligase IV in PKA-dependent pathways supports the hypothesis that cAMP signaling might inhibit NHEJ repair of DSBs by differential modulation of DNA-PKcs phosphorylation in lung cancer cells.